Updated On: 18 August, 2020 10:54 AM IST | Mumbai | mid-day online correspondent
Vipul Amrutlal Shahs next offering Humans, a web series based on human drug testing that would unravel the shades of grey, risk-taking measures, loopholes and disparity in our bid to develop the vaccine.

Vipul Amrutlal Shah
The medical experts and scientists across the globe are working round-the-clock to develop a vaccine to combat the rapidly spreading coronavirus. Given the urgency to stem the spread of COVID-19, some drug makers are moving straight into small-scale human tests, without waiting for the completion of pre-human testing procedures. Needless to say, the race to develop the vaccine in a cost-effective manner among the countries has raised several questions on the modus operandi. Clinical trials test potential treatments in human volunteers to see whether they should be approved for wider use in the general population. A treatment could be a drug, medical device, or biologic, such as a vaccine, blood product, or gene therapy.
While no filmmaker so far has thought of attempting a subject like this, writer-producer-director Vipul Amrutlal Shah has consciously decided to chart a challenging and unexplored territory with his next offering, Humans, a web series based on human drug testing that would unravel the shades of grey, risk-taking measures, loopholes and disparity in our bid to develop the vaccine.